reveromycin a has been researched along with Disease Models, Animal in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Asano, Y; Goto, S; Kako, S; Kawatani, M; Maeda, H; Miyazawa, K; Osada, H; Tabuchi, M | 1 |
| Goto, S; Kadota, M; Kawatani, M; Maeda, H; Miyazawa, K; Osada, H; Shoji, S; Tabuchi, M; Tanaka, M; Yabumoto, T; Yoshizako, M | 1 |
| Goto, S; Kawatani, M; Maeda, H; Minamoto, C; Miyazawa, K; Mizuno, M; Osada, H; Tabuchi, M; Tamaoka, Y; Tanaka, M; Torii, Y; Yoshizako, M | 1 |
| Osada, H | 1 |
| Fotovati, A; Hiraoka, K; Hosoi, F; Iguchi, H; Kimura, YN; Kuwano, M; Nagata, K; Ono, M; Osada, H; Shoda, T; Watari, K; Zenmyo, M | 1 |
| Goto, S; Kadota, M; Kawatani, M; Maeda, H; Miyazawa, K; Osada, H; Tabuchi, M; Tanaka, M; Yabumoto, T; Yamane, C; Yoshizako, M | 1 |
1 review(s) available for reveromycin a and Disease Models, Animal
| Article | Year |
|---|---|
Chemical and biological studies of reveromycin A.
Topics: Animals; Antibiotics, Antineoplastic; Cell Line, Tumor; Disease Models, Animal; Drug Discovery; Humans; Mice; Osteoclasts; Pyrans; Spiro Compounds; Structure-Activity Relationship | 2016 |
5 other study(ies) available for reveromycin a and Disease Models, Animal
| Article | Year |
|---|---|
Local administration of ReveromycinA ointment suppressed alveolar bone loss in mice.
Topics: Administration, Topical; Alveolar Bone Loss; Animals; Bone Resorption; Disease Models, Animal; Male; Mice, Inbred C57BL; Mice, Knockout; Ointments; Osteoclasts; Periodontal Diseases; Periodontitis; Pyrans; Spiro Compounds | 2021 |
Stabilization of tooth movement by administration of reveromycin A to osteoprotegerin-deficient knockout mice.
Topics: Alveolar Bone Loss; Animals; Antimitotic Agents; Bone Remodeling; Core Binding Factor Alpha 1 Subunit; Dental Stress Analysis; Disease Models, Animal; Injections, Intraperitoneal; Male; Mice; Mice, Knockout; Osteitis Deformans; Osteoprotegerin; Pyrans; Secondary Prevention; Spiro Compounds; Tooth Movement Techniques | 2013 |
Reveromycin A Administration Prevents Alveolar Bone Loss in Osteoprotegerin Knockout Mice with Periodontal Disease.
Topics: Alveolar Bone Loss; Animals; Cytokines; Disease Models, Animal; Inflammation Mediators; Male; Mice; Mice, Knockout; Osteoclasts; Osteoprotegerin; Periodontal Diseases; Pyrans; Spiro Compounds; X-Ray Microtomography | 2015 |
Inhibition of bone and muscle metastases of lung cancer cells by a decrease in the number of monocytes/macrophages.
Topics: Animals; Bone Density Conservation Agents; Bone Neoplasms; Clodronic Acid; Disease Models, Animal; Female; Humans; Lung Neoplasms; Macrophages; Mice; Mice, Inbred BALB C; Monocytes; Muscle Neoplasms; Neoplasm Invasiveness; Pyrans; Spiro Compounds | 2008 |
Effect of Reveromycin A on experimental tooth movement in OPG-/- mice.
Topics: Acid Phosphatase; Alkaline Phosphatase; Alveolar Process; Animals; Biomarkers; Bone Density Conservation Agents; Bone Remodeling; Bone Resorption; Cell Count; Dental Alloys; Disease Models, Animal; Injections, Intraperitoneal; Isoenzymes; Male; Maxilla; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Mice, Knockout; Mutation; Nickel; Orthodontic Wires; Osteitis Deformans; Osteoclasts; Osteoporosis; Osteoprotegerin; Pyrans; Spiro Compounds; Tartrate-Resistant Acid Phosphatase; Titanium; Tooth Movement Techniques; X-Ray Microtomography | 2012 |